BiotechTube

Isavuconazole + Caspofungin + Voriconazole

Phase 3Completed
4 views this week 0 watching⚡ Active
Interest: 40/100
40
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Candidiasis, Invasive

Conditions

Candidiasis, Invasive, Candidemia, Mycoses

Trial Timeline

Mar 8, 2007 → Mar 3, 2015

NCT ID
NCT00413218

About Isavuconazole + Caspofungin + Voriconazole

Isavuconazole + Caspofungin + Voriconazole is a phase 3 stage product being developed by Astellas Pharma for Candidiasis, Invasive. The current trial status is completed. This product is registered under clinical trial identifier NCT00413218. Target conditions include Candidiasis, Invasive, Candidemia, Mycoses.

What happened to similar drugs?

5 of 20 similar drugs in Candidiasis, Invasive were approved

Approved (5) Terminated (4) Active (12)
✅Fluconazole + MicafunginAstellas PharmaApproved
✅Caspofungin + Normal SalineMerckApproved
✅VoriconazolePfizerApproved
✅Eraxis (anidulafungin) + Diflucan (fluconazole) + Vfend (voriconazole)PfizerApproved
✅Clotrimazole vaginal tablet + FluconazoleBayerApproved
🔄Micafungin + fluconazoleAstellas PharmaPhase 3
🔄Micafungin + CaspofunginAstellas PharmaPhase 3

Hype Score Breakdown

Clinical
17
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT00413218Phase 3Completed

Competing Products

20 competing products in Candidiasis, Invasive

See all competitors
ProductCompanyStageHype Score
MicafunginAstellas PharmaPhase 1
29
Micafungin + fluconazoleAstellas PharmaPhase 3
40
Micafungin (Mycamine)Astellas PharmaPhase 1
29
Fluconazole + MicafunginAstellas PharmaApproved
35
Micafungin + CaspofunginAstellas PharmaPhase 3
40
Micafungin + FluconazoleAstellas PharmaPhase 3
40
MicafunginAstellas PharmaPhase 2
35
micafungin + caspofunginAstellas PharmaPhase 3
40
micafungin + amphotericin B deoxycholateAstellas PharmaPhase 3
32
FK463Astellas PharmaPhase 2
35
Micafungin + Liposomal Amphotericin BAstellas PharmaPhase 3
40
SHR8008 + FluconazoleJiangsu Hengrui MedicinePhase 3
36
SHR8008 capsule + Fluconazole capsuleJiangsu Hengrui MedicinePhase 3
36
L-743,872MerckPre-clinical
26
CaspofunginMerckPhase 2
35
L-743,872MerckPhase 2
27
Caspofungin + Amphotericin B DeoxycholateMerckPhase 2
27
Caspofungin acetate + PlaceboMerckPhase 2
27
Caspofungin + Normal SalineMerckApproved
43
caspofungin acetateMerckPhase 3
40